{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:40Z","timestamp":1761514420480,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10428"],"award-info":[{"award-number":["17K10428"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13550-019-0525-6","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T12:02:49Z","timestamp":1562328169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO"],"prefix":"10.1186","volume":"9","author":[{"given":"Shiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-3507","authenticated-orcid":false,"given":"Tohru","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Magota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Toyonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Higashikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagara","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"525_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10147-015-0920-6","volume":"21","author":"N Tamaki","year":"2016","unstructured":"Tamaki N, Hirata K. Tumor hypoxia: a new PET imaging biomarker in clinical oncology. Int J Clin Oncol. 2016;21:619\u201325.","journal-title":"Int J Clin Oncol"},{"key":"525_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","volume":"22","author":"WJ Koh","year":"1992","unstructured":"Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys. 1992;22:199\u2013212.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"525_CR3","first-page":"68","volume":"28","author":"Z Grunbaum","year":"1987","unstructured":"Grunbaum Z, Freauff SJ, Ka K, Wilbur DS, Magee S, Rasey JS. Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J Nucl Med. 1987;28:68\u201375.","journal-title":"J Nucl Med"},{"key":"525_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.111.099770","volume":"53","author":"S Carlin","year":"2012","unstructured":"Carlin S, Humm JL. PET of hypoxia: current and future perspectives. J Nucl Med. 2012;53:1171\u20134.","journal-title":"J Nucl Med"},{"key":"525_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijrobp.2014.09.045","volume":"91","author":"SGJA Peeters","year":"2015","unstructured":"Peeters SGJA, Zegers CML, Lieuwes NG, van Elmpt W, Eriksson J, van Dongen GAMS, et al. A comparative study of the hypoxia PET tracers [(1)(8)F]HX4, [(1)(8)F]FAZA, and [(1)(8)F]FMISO in a preclinical tumor model. Int J Radiat Oncol Biol Phys. 2015;91:351\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"525_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3109\/0284186X.2015.1067721","volume":"54","author":"LJ Wack","year":"2015","unstructured":"Wack LJ, Monnich D, van Elmpt W, Zegers CML, Troost EGC, Zips D, et al. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study. Acta Oncol. 2015;54:1370\u20137.","journal-title":"Acta Oncol"},{"issue":"1","key":"525_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11307-018-1214-y","volume":"21","author":"Yoichi Shimizu","year":"2018","unstructured":"Shimizu Y, Zhao S, Yasui H, Nishijima K-I, Matsumoto H, Shiga T, et al. A novel PET probe \u201c[(18)F]DiFA\u201d accumulates in hypoxic region via glutathione conjugation following reductive metabolism. Mol Imaging Biol. 2019;21:122\u20139.","journal-title":"Molecular Imaging and Biology"},{"key":"525_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.nucmedbio.2005.06.003","volume":"32","author":"SJ Oh","year":"2005","unstructured":"Oh SJ, Chi DY, Mosdzianowski C, Kim JY, Gil HS, Kang SH, et al. Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module. Nucl Med Biol. 2005;32:899\u2013905.","journal-title":"Nucl Med Biol"},{"key":"525_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.nucmedbio.2005.03.010","volume":"32","author":"G Tang","year":"2005","unstructured":"Tang G, Wang M, Tang X, Gan M, Luo L. Fully automated one-pot synthesis of [18F]fluoromisonidazole. Nucl Med Biol. 2005;32:553\u20138.","journal-title":"Nucl Med Biol"},{"key":"525_CR10","unstructured":"Investigator\u2019s Brochure for [18F]FMISO. Cancer Imaging Program Division of Cancer Treatment and Diagnosis National Cancer Institute National Institutes of Health. Release Date: February 2013. Available at: https:\/\/www.acrin.org\/Portals\/0\/Protocols\/6697\/6697_FMISO%20-IB_Edition5_ReleaseDate-February5,%202013.pdf . Accessed 24 Apr 2019."},{"key":"525_CR11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2967\/jnumed.113.122671","volume":"58","author":"A Savi","year":"2017","unstructured":"Savi A, Incerti E, Fallanca F, Bettinardi V, Rossetti F, Monterisi C, et al. First evaluation of PET-based human biodistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia. J Nucl Med. 2017;58:1224\u20139.","journal-title":"J Nucl Med"},{"key":"525_CR12","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"525_CR13","first-page":"1631","volume":"38","author":"MM Graham","year":"1997","unstructured":"Graham MM, Peterson LM, Link JM, Evans ML, Rasey JS, Koh WJ, et al. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. J Nucl Med. 1997;38:1631\u20136.","journal-title":"J Nucl Med"},{"key":"525_CR14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/MNM.0b013e3283407950","volume":"31","author":"M Doss","year":"2010","unstructured":"Doss M, Zhang JJ, Belanger M-J, Stubbs JB, Hostetler ED, Alpaugh K, et al. Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET\/CT. Nucl Med Commun. 2010;31:1016\u201324.","journal-title":"Nucl Med Commun"},{"key":"525_CR15","first-page":"1674","volume":"43","author":"T Tolvanen","year":"2002","unstructured":"Tolvanen T, Lehtio K, Kulmala J, Oikonen V, Eskola O, Bergman J, et al. 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies. J Nucl Med. 2002;43:1674\u201380.","journal-title":"J Nucl Med"},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2307\/3575246","volume":"82","author":"JM Brown","year":"1980","unstructured":"Brown JM, Workman P. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res. 1980;82:171\u201390.","journal-title":"Radiat Res"},{"key":"525_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.112.109330","volume":"54","author":"S Okamoto","year":"2013","unstructured":"Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, et al. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med. 2013;54:201\u20137.","journal-title":"J Nucl Med"},{"key":"525_CR18","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1088\/0031-9155\/54\/10\/008","volume":"54","author":"W Wang","year":"2009","unstructured":"Wang W, Georgi J-C, Nehmeh SA, Narayanan M, Paulus T, Bal M, et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol. 2009;54:3083\u201399.","journal-title":"Phys Med Biol"},{"key":"525_CR19","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1088\/0031-9155\/50\/10\/002","volume":"50","author":"D Thorwarth","year":"2005","unstructured":"Thorwarth D, Eschmann SM, Paulsen F, Alber M. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol. 2005;50:2209\u201324.","journal-title":"Phys Med Biol"},{"key":"525_CR20","first-page":"1027","volume":"58","author":"H Yasui","year":"2017","unstructured":"Yasui H, Zhao S, Higashikawa K, Ukon N, Shimizu Y, Matsumoto H, et al. Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO. J Nucl Med [Internet]. 2017;58:1027.","journal-title":"J Nucl Med [Internet]"},{"key":"525_CR21","first-page":"373","volume":"56","author":"K Kobayashi","year":"2015","unstructured":"Kobayashi K, Hirata K, Yamaguchi S, Kobayashi H, Terasaka S, Manabe O, et al. FMISO PET at 4 hours showed a better lesion-to-background ratio uptake than 2 hours in brain tumors. J Nucl Med. 2015;56:373.","journal-title":"J Nucl Med"},{"key":"525_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00259-011-2037-0","volume":"39","author":"K Hirata","year":"2012","unstructured":"Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H, et al. (1)(8)F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging. 2012;39:760\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"525_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/MNM.0b013e3283529984","volume":"33","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Maeda Y, Kawai N, Kudomi N, Aga F, Ono Y, et al. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. Nucl Med Commun. 2012;33:621\u20135.","journal-title":"Nucl Med Commun"},{"key":"525_CR24","first-page":"365","volume":"4","author":"E Lopci","year":"2014","unstructured":"Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, et al. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence. Am J Nucl Med Mol Imaging. 2014;4:365\u201384.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"525_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nucmedbio.2019.01.008","volume":"70","author":"N Nakata","year":"2019","unstructured":"Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima K-I, Shiga T, et al. Comparative evaluation of [(18)F]DiFA and its analogs as novel hypoxia positron emission tomography and [(18)F]FMISO as the standard. Nucl Med Biol. 2019;70:39\u201345.","journal-title":"Nucl Med Biol"},{"key":"525_CR26","doi-asserted-by":"publisher","first-page":"e0157606","DOI":"10.1371\/journal.pone.0157606","volume":"11","author":"Y Wei","year":"2016","unstructured":"Wei Y, Zhao W, Huang Y, Yu Q, Zhu S, Wang S, et al. A comparative study of noninvasive hypoxia imaging with 18F-fluoroerythronitroimidazole and 18F-fluoromisonidazole PET\/CT in patients with lung cancer. PLoS One. 2016;11:e0157606.","journal-title":"PLoS One"},{"key":"525_CR27","first-page":"1523","volume":"53","author":"N Nakata","year":"2012","unstructured":"Nakata N, Okumura Y, Nagata E, Kiriu M, Hayashi A, Nishijima K, et al. Evaluation of a new PET hypoxia tracer, [18F]HIC101, in comparison with [18F]FMISO. J Nucl Med. 2012;53:1523.","journal-title":"J Nucl Med"},{"key":"525_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep16802","volume":"5","author":"Y Masaki","year":"2015","unstructured":"Masaki Y, Shimizu Y, Yoshioka T, Tanaka Y, Nishijima K-I, Zhao S, et al. The accumulation mechanism of the hypoxia imaging probe \u201cFMISO\u201d by imaging mass spectrometry: possible involvement of low-molecular metabolites. Sci Rep. 2015;5:16802.","journal-title":"Sci Rep"},{"key":"525_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s12149-017-1189-9","volume":"31","author":"Y Masaki","year":"2017","unstructured":"Masaki Y, Shimizu Y, Yoshioka T, Nishijima K-I, Zhao S, Higashino K, et al. FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state. Ann Nucl Med. 2017;31:596\u2013604.","journal-title":"Ann Nucl Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0525-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-019-0525-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0525-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T04:27:28Z","timestamp":1610252848000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-019-0525-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1186\/s13550-019-0525-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"type":"electronic","value":"2191-219X"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Ethics Committee of Hokkaido University Hospital approved this study (#015-0372 and #017-0154 for healthy volunteer and patient studies, respectively), and written informed consent was obtained from each subject.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HM is an employee of Nihon Medi-Physics Co., Ltd. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}